Article ; Online: Development of rapidly dissolving pellets within the Quality by Design approach.
Drug development and industrial pharmacy
2017 Volume 43, Issue 5, Page(s) 770–779
Abstract: The purpose of this study was the development of novel, fast disintegrating, effervescent pellets by employing the direct pelletization technique as a single step process. In line with the Quality by Design (QbD) regulatory framework, statistical ... ...
| Abstract | The purpose of this study was the development of novel, fast disintegrating, effervescent pellets by employing the direct pelletization technique as a single step process. In line with the Quality by Design (QbD) regulatory framework, statistical experimental design was extensively applied to correlate significant formulation and process variables with the critical quality attributes of the product. Pellets were studied with regards to sphericity, size and size distribution. In contrast to the existing multiparticulate platforms, this development integrated only water-soluble excipients to facilitate the multifunctional use of the final dosage form. The application of a screening fractional factorial design augmented to a full factorial design set the roadmap for the rational selection of the composition and process parameters, revealing in parallel the positive contribution of the powder feeder on the CQAs, when the critical process and formulation factors were properly adjusted. The response surface methodology was exploited for the final process optimization phase, which allowed the construction of appropriate mathematical models connecting the input variables and the CQAs under study. The implementation of the desirability function, lead to the optimum formulation and process settings for the production of pellets with narrow size distribution and geometric mean diameter of approximately 800 μm. In conclusion, using a lean approach supported by design of experiments (DoE) techniques within the QbD framework, a novel multifunctional formulation platform has been developed. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Chemistry, Pharmaceutical/methods ; Drug Implants/chemistry ; Excipients/chemistry ; Models, Theoretical ; Particle Size ; Powders/chemistry ; Solubility ; Technology, Pharmaceutical/methods ; Water/chemistry | |||||
| Chemical Substances | Drug Implants ; Excipients ; Powders ; Water (059QF0KO0R) | |||||
| Language | English | |||||
| Publishing date | 2017-05 | |||||
| Publishing country | England | |||||
| Document type | Journal Article | |||||
| ZDB-ID | 751874-2 | |||||
| ISSN | 1520-5762 ; 0363-9045 | |||||
| ISSN (online) | 1520-5762 | |||||
| ISSN | 0363-9045 | |||||
| DOI | 10.1080/03639045.2016.1220576 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1335: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.